Veramyst Related Published Studies
Well-designed clinical trials related to Veramyst (Fluticasone Nasal)
An integrated analysis of the efficacy of fluticasone furoate nasal spray versus
placebo on the nasal symptoms of perennial allergic rhinitis. [2013]
MP29-02 (a novel intranasal formulation of azelastine hydrochloride and
fluticasone propionate) in the treatment of seasonal allergic rhinitis: a
randomized, double-blind, placebo-controlled trial of efficacy and safety. [2012]
Effect of fluticasone furoate on interleukin 6 secretion from adenoid tissues in children with obstructive sleep apnea. [2011.06]
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. [2011.04]
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment
of perennial allergic rhinitis. [2011]
Fluticasone furoate nasal spray is effective and well tolerated for perennial allergic rhinitis in adolescents and adults. [2010.11]
Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. [2010.09.01]
Quality of life is improved by endoscopic surgery and fluticasone in nasal polyposis with asthma. [2010.09]
Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. [2010.08]
Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. [2010.08]
Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. [2010.07.01]
Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study. [2010.04]
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. [2010.01]
An integrated analysis of the efficacy of fluticasone furoate nasal spray on
individual nasal and ocular symptoms of seasonal allergic rhinitis. [2010]
Quality of life is improved by endoscopic surgery and fluticasone in nasal
polyposis with asthma. [2010]
Double-blind, placebo-controlled study of azelastine and fluticasone in a single
nasal spray delivery device. [2010]
Effect of the addition of montelukast to fluticasone propionate for the treatment
of perennial allergic rhinitis. [2010]
Comparison of patient preference for sensory attributes of fluticasone furoate or
fluticasone propionate in adults with seasonal allergic rhinitis: a randomized,
placebo-controlled, double-blind study. [2010]
Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound
congestion. [2010]
Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device. [2009.12]
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. [2009.06]
Long-term study of fluticasone propionate aqueous nasal spray in acute and maintenance therapy of nasal polyposis. [2009.06]
Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. [2009.06]
Effectiveness of fluticasone furoate 110 mug once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen * [2009.05.06]
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. [2009.05]
HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis. [2009.05]
Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. [2009.05]
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. [2009.03]
Comparative safety and efficacy of 2 formulations of fluticasone aqueous nasal spray in persistent allergic rhinitis. [2009.01]
Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis. [2009.01]
Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. [2008.05]
Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. [2008.05]
Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. [2008.01]
Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. [2008.01]
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. [2007.09]
Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. [2007.09]
Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. [2007.09]
A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis. [2007.08]
Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. [2007.07]
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. [2007.06]
Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. [2007.03]
Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. [2007.03]
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. [2006.06]
Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses. [2006.06]
Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. [2006.05]
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. [2005.10]
Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. [2005.07]
Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. [2005.05]
Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. [2005.03]
A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. [2005]
Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity. [2004.11]
The effect of fluticasone on the airway inflammatory response to organic dust. [2004.10]
Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. [2004.09]
Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis. [2004.06]
Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. [2004.06]
Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. [2004.06]
Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. [2004.03]
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. [2004.02]
Triamcinolone acetonide and fluticasone propionate aqueous nasal sprays significantly improve nasal airflow in patients with seasonal allergic rhinitis. [2004.01]
Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis. [2004.01]
Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers. [2004.01]
Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. [2003.12]
Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia. [2003.09]
Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray. [2003.08]
Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). [2003.07]
Well-designed clinical trials possibly related to Veramyst (Fluticasone Nasal)
Corticosteroids for the common cold. [2012]
Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial. [2011.03.01]
Topical nasal steroid treatment does not improve CPAP compliance in unselected patients with OSAS. [2011.02]
Efficacy and safety of montelukast add-on therapy in allergic rhinitis. [2010.11]
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. [2010.03]
Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis. [2010.03]
Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen. [2010]
Evaluation of olopatadine hydrochloride nasal spray, 0.6%, used in combination
with an intranasal corticosteroid in seasonal allergic rhinitis. [2010]
Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. [2009.10.15]
Functional endoscopic sinus surgery improved asthma symptoms as well as PEFR and olfaction in patients with nasal polyposis. [2009.05]
Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. [2009.03]
Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis. [2008]
[Clinical observation on treatment of children's mild continuous asthma by Fangchuan Mixture combined with flixotide] [2007.11]
Nasal epithelial cells express IL-10 at levels that negatively correlate with clinical symptoms in patients with house dust mite allergy. [2007.09]
Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis. [2007.09]
A proof-of-concept study to assess the putative dose response to topical corticosteroid in persistent allergic rhinitis using adenosine monophosphate challenge. [2007.05]
Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. [2007.03]
Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. [2007.01]
Treatment of allergic rhinitis can improve blood pressure control. [2006.11]
Influence of anatomy and head position on intranasal drug deposition. [2006.09]
Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients. [2006.03]
Recovery of the ciliated epithelium following acute bronchiolitis in infancy. [2005.07]
Evaluation of an intranasal house dust mite provocation model as a tool in clinical research. [2005.06]
Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis. [2005.05]
Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid. [2005.01]
[Effects of intranasal cortocosteroidson on the expression of Aquaporin-5 in human nasal polyps] [2004.11]
Prostaglandins, leukotrienes and perennial rhinitis. [2004.07]
Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. [2004.05]
Intranasal loteprednol etabonate in healthy male subjects: pharmacokinetics and effects on endogenous cortisol. [2004.05]
Infections after endoscopic polypectomy using nasal steroids. [2004.03]
Effects of three nasal topical steroids in the intraocular pressure compartment. [2004.02]
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. [2004.01]
Comparisons of two intranasal corticosteroid preparations in treating allergic rhinitis. [2003.11]
Other research related to Veramyst (Fluticasone Nasal)
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of
azelastine hydrochloride and fluticasone propionate in an advanced delivery
system) in subjects with chronic rhinitis. [2014]
The use of large volume low pressure nasal saline with fluticasone propionate for
the treatment of pediatric acute rhinosinusitis. [2014]
Fluticasone nasal spray as an adjunct to Amoxicillin for acute sinusitis in
children: a randomized controlled trial. [2013]
|
